A key trend shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market involves the Shift Toward Outpatient, Low-Invasiveness Procedures Supporting Market Evolution
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Over The 2026–2030 Period?
The market for benign prostatic hyperplasia (BPH) treatment devices and equipment has shown significant growth in recent years. It is forecast to grow from $1.34 billion in 2025 to $1.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.3%. This historical expansion can be attributed to factors such as the increasing prevalence of benign prostatic hyperplasia, a rise in awareness regarding urological disorders, the adoption of transurethral procedures, the expansion of hospital urology departments, and enhancements in endoscopic surgical tools.
The benign prostatic hyperplasia (bph) treatment devices and equipment market size is projected to experience substantial expansion over the coming years, growing to **$1.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%.** This projected growth during the forecast period is primarily driven by factors such as a growing aging male demographic, a heightened inclination towards minimally invasive therapies, the proliferation of outpatient urology clinics, the increasing integration of laser and implant-based interventions, and an intensified emphasis on shorter hospitalizations. Key trends anticipated for this period encompass a wider embrace of minimally invasive BPH treatment devices, an escalation in the utilization of laser-based prostate therapies, a surging demand for implant-based treatment alternatives, the expansion of BPH procedures performed in office settings, and an elevated prioritization of patient comfort and recovery.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp
What Underlying Factors Are Accelerating The Growth Of The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
The anticipated surge in prostate cancer diagnoses is expected to stimulate the expansion of the benign prostatic hyperplasia market going forward. Prostate cancer is a malignancy that originates in the prostate gland, which is a compact, walnut-sized organ positioned just below the bladder in men. An increase in prostate cancer cases frequently results in a greater number of older men seeking medical attention for prostate-related issues. This, in turn, facilitates the identification and management of benign prostatic hyperplasia. For instance, in February 2023, information from the American Society of Clinical Oncology (ASCO), a US-based professional organization that publishes patient information on the cancer.net website, revealed an estimated 288,300 men in the United States were living with prostate cancer in 2023. Furthermore, in 2022, there were 268,490 new cases and 34,500 deaths attributed to prostate cancer. Consequently, the rising number of prostate cancer cases is driving the growth of the benign prostatic hyperplasia market.
How Is The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Segmented Across Key Categories?
The benign prostatic hyperplasia (bph) treatment devices and equipment market covered in this report is segmented –
1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants
2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types
3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Specialty Urology Centers
Subsegments:
1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes
2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation
3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers
4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents
5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment
Which Upcoming Trends Are Expected To Influence The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?
Leading companies in the benign prostatic hyperplasia (BPH) treatment devices and equipment market are prioritizing the creation of innovative, minimally invasive solutions, such as temporarily implantable devices. These advancements aim to broaden access to outpatient treatment and lessen reliance on prolonged medication or tissue-removal surgeries. Temporarily implantable BPH devices function as single-use or short-term implants, engineered to reconfigure the prostatic urethra and alleviate lower urinary tract symptoms (LUTS) stemming from an enlarged prostate. For example, in February 2025, Olympus, a Japan-based medical technology company, announced a significant milestone for its iTind device, expanding its availability across major APAC markets including Thailand, Australia, Hong Kong, Singapore, and India, with a planned launch in Korea. Olympus underscored that the iTind procedure is a minimally invasive, clinic-room option that can be performed under local anaesthesia and is backed by a thorough physician training programme to support clinical integration. The iTind is a temporarily implantable nitinol device that remodels the prostatic urethra to enhance urinary flow and patient quality of life, with recent guideline and reimbursement developments contributing to its accelerated adoption.
Who Are The Dominant Players Shaping The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Landscape?
Major companies operating in the benign prostatic hyperplasia (bph) treatment devices and equipment market are Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston Scientific Inc., NeoTract Inc., OmniGuide Inc., ProArc Medical Ltd., Urotech Devices, Prostalund Operations AB, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, PROCEPT BioRobotics, Quanta System
Read the full benign prostatic hyperplasia (bph) treatment devices and equipment market report here:
Which Region Is Projected To Dominate The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market During The Forecast Period?
North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2025. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (bph) treatment devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp
Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2026, By The Business Research Company
Drugs For Benign Prostatic Hypertrophy Market Report 2026
Prostate Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
